Literature DB >> 14960538

Treatment of interferon non-responsive chronic hepatitis C with triple therapy with interferon, ribavirin, and amantidine can be encouraging.

N Khokhar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960538      PMCID: PMC1773994     

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.

Authors:  S Brillanti; F Levantesi; L Masi; M Foli; L Bolondi
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

Review 3.  National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

Authors: 
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial.

Authors:  L E Adinolfi; R Utili; A Tonziello; G Ruggiero
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

5.  The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C.

Authors:  Hideji Nakamura; Hirokazu Uyama; Hirayuki Enomoto; Yoshihiko Kishima; Mitsunari Yamamoto; Kenya Yoshida; Yorihide Okuda; Tomonori Hirotani; Toshifumi Kuroda; Hiroaki Ito; Masahiro Matsuda; Minoru Terabayashi; Sanai Noguchi
Journal:  Hepatogastroenterology       Date:  2003 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.